SECOND REGULAR SESSION
96TH GENERAL ASSEMBLY
INTRODUCED BY REPRESENTATIVES KIRKTON (Sponsor), WALTON GRAY, OXFORD, PACE, McCREERY AND NEWMAN (Co-sponsors).
5346L.01I D. ADAM CRUMBLISS, Chief Clerk
AN ACT
To repeal section 191.332, RSMo, and to enact in lieu thereof one new section relating to newborn screening requirements.
Be it enacted by the General Assembly of the state of Missouri, as follows:
Section A. Section 191.332, RSMo, is repealed and one new section enacted in lieu thereof, to be known as section 191.332, to read as follows:
191.332. 1. By January 1, 2002, the department of health and senior services shall, subject to appropriations, expand the newborn screening requirements in section 191.331 to include potentially treatable or manageable disorders, which may include but are not limited to cystic fibrosis, galactosemia, biotinidase deficiency, congenital adrenal hyperplasia, maple syrup urine disease (MSUD) and other amino acid disorders, glucose-6-phosphate dehydrogenase deficiency (G-6-PD), MCAD and other fatty acid oxidation disorders, methylmalonic acidemia, propionic acidemia, isovaleric acidemia and glutaric acidemia Type I.
2. By January 1, 2013, the department of health and senior services shall, subject to appropriations, expand the newborn screening requirements in section 191.331 to include severe combined immune deficiency disease (SCID), also known as bubble boy disease.
3. The department of health and senior services may promulgate rules to implement the provisions of this section. No rule or portion of a rule promulgated pursuant to the authority of this section shall become effective unless it has been promulgated pursuant to chapter 536.
•